XBiotech (XBIT) Current Taxes (2019 - 2025)

XBiotech (XBIT) posted quarterly Current Taxes of $76000.0 for Q4 2025, down 24.0% quarter-over-quarter from $100000.0 in Q3 2025.

XBiotech (XBIT) Current Taxes (2019 - 2025) Analysis & Trends

XBiotech's Current Taxes history runs 7 years deep, the most recent figure standing at $76000.0 for Q4 2025.

In Q4 2025, Current Taxes changed N/A year-over-year to $76000.0; the TTM figure through Dec 2025 stood at $76000.0 (changed N/A YoY), while the FY2025 annual figure was $76000.0, changed N/A from the prior year.
Current Taxes for Q4 2025 stood at $76000.0, down from $100000.0 in the prior quarter.
The five-year high for Current Taxes was $1.2 million in Q3 2021, with the low at $7000.0 in Q1 2025.
The 5-year median for Current Taxes is $83000.0 (2023), against an average of $200062.5.
Peak annual rise in Current Taxes reached 5381.82% in 2021, while the deepest fall reached 92.96% in 2021.
XBiotech's Current Taxes stood at $10000.0 in 2021, then soared by 450.0% to $55000.0 in 2022, then soared by 50.91% to $83000.0 in 2023, then changed by 0.0% to $83000.0 in 2024, then slipped by 8.43% to $76000.0 in 2025.
Business Quant data shows XBIT's Current Taxes at $76000.0 in Q4 2025, $100000.0 in Q3 2025, and $16000.0 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	-
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	49.00 Mn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	-
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	76.32 Mn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	-
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	-
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	76.36 Mn
10	XBiotech	68.90 Mn	68.90 Mn	-	-

Download Data